Viewing Study NCT06228066

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:25 PM
Ignite Modification Date: 2025-12-27 @ 8:06 AM
Study NCT ID: NCT06228066
Status: RECRUITING
Last Update Posted: 2025-12-10
First Post: 2024-01-26
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Lurbinectedin With or Without Avelumab in Small Cell Carcinoma of the Bladder (LASER)
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Small Cell Carcinoma of the Bladder View
None High Grade Neuroendocrine Tumors of the Urinary Tract View
Keywords:

Keywords

Keyword Brief Keyword Text View
None High grade neuroendocrine tumors View
None small cell neuroendocrine carcinoma View
None large cell neuroendocrine carcinoma View
None transcription factor inhibitor View
None Immunotherapy View
None programmed cell death 1 ligand 1 View